Author | Year | Age | Sex (Male/Female) | Type of sugery | Comparisons | Timing of administration | Nausea | Vomiting | Total |
---|---|---|---|---|---|---|---|---|---|
Aniskevich, S | 2014 | 23–79 years | 6/4 | Laparoscopic hand-assisted nephrectomy | TAP 0.5% ropivacaine 100 mg | Before surgery | 5 | 2 | 10 |
 |  |  | 6/5 |  | Control saline 20 ml |  | 10 | 2 | 11 |
Bharti, N | 2011 | 18–60 years | 14/6 | Colorectal surgery | TAP 0.25% bupivacaine 50 mg | At the end of surgery | 8 | 4 | 40 |
 |  |  | 14/6 |  | Control saline 20 ml |  | 4 | - | 40 |
Bhattacharjee, S | 2014 | - | 0/45 | Total abdominal hysterectomy by a lower abdominal transverse incision | TAP 0.25%bupivacaine 100Â mg | Before anesthesia | 8 | - | 45 |
 |  | - | 0/45 |  | Control saline 40 ml |  | 12 | - | 45 |
Cevikkalp, E | 2023 | 18–70 years | 11/24 | Laparoscopic cholecystectomy | TAP 0.25%bupivacaine 100 mg | Before anesthesia | 9 | - | 35 |
 |  |  | 7/27 |  | Control saline 40 ml |  | 9 | - | 34 |
Covotta, M | 2020 | ≥ 18 years | 30/18 | Robotic partial nephrectomy | TAP 0.5% ropivacaine 150 mg | After induction of general anesthesia | 9 | - | 48 |
 |  |  | 22/26 |  | Control nothing |  | 18 | - | 48 |
Geng, Z. Y | 2023 | 18–65 years | 0/32 | Elective open gynecological surgery | TAP 0.375% ropivacaine 75 mg | After induction of anesthesia and before surgery | 8 | 7 | 32 |
 |  |  | 0/32 |  | Control saline 20 ml |  | 16 | 7 | 32 |
Guo, J. G | 2018 | 18–65 years | 25/10 | Open liver resection | TAP0.375% ropivacaine 75 mg | Before anesthesia | 2 | 2 | 35 |
 |  |  | 23/12 |  | Control saline 20 ml |  | 8 | 4 | 35 |
Hutchins, J | 2014 | - | 0/30 | Robotic assisted hysterectomy | TAP 0.25%bupivacaine 37.5Â mg | After induction of general anesthesia | 6 | - | 30 |
 |  | - | 0/30 |  | Control nothing |  | 16 | - | 30 |
Kawahara, R | 2015 | ≥ 18 years | 0/60 | Gynecologic laparoscopic surgery | TAP 0.375% ropivacaine 75 mg | Following general anesthesia | 11 | - | 60 |
 |  |  | 0/59 |  | Control saline 20 ml |  | 21 | - | 59 |
Keller, D | 2014 | > 18 years | 18/23 | Laparoscopic colorectal Surgery | TAP0.5% bupivacaine 150 mg | At the completion of the procedure | 10 | - | 41 |
 |  |  | 16/22 |  | Control saline 30 ml |  | 9 | - | 38 |
Kim, M. G | 2014 | ≥ 18 years | 31/2 | Laparoscopic totally extraperitoneal hernia repair | TAP 0.375% ropivacaine112.5 mg | After induction of general anesthesia | 6 | - | 33 |
 |  |  | 33/4 |  | Control nothing |  | 5 | - | 37 |
Korkmaz Toker, M | 2019 | 18–65 years | 0/30 | Laparoscopic hysterectomy for benign gynecologic pathologies | TAP 0.375% bupivacaine 150 mg | Before the initiation of surgery | 11 | - | 30 |
 |  |  | 0/30 |  | Control saline 40 ml |  | 15 | - | 30 |
Li, X | 2019 | 18–70 years | 32/20 | Retroperitoneoscopic renal surgery | TAP0.4% ropivacaine 120 mg | After induction of general anesthesia | 17 | - | 52 |
 |  |  | 31/20 |  | Control saline 30 ml |  | 15 | - | 51 |
Lochel, J | 2021 | ≥ 18 years | - | Periacetabular osteotomy | TAP 0.75% ropivacaine 150 mg | After induction of general anesthesia | 9 | 1 | 21 |
 |  |  | - |  | Control nothing |  | 9 | 1 | 20 |
Lu, X | 2020 | > 18 years | 59/4 | Laparoscopic hepatectomy | TAP 0.25% ropivacaine 100 mg | At the end of surgery | 21 | 15 | 63 |
 |  |  | 45/18 |  | Control nothing |  | 22 | 16 | 63 |
Ma, J | 2018 | 18–75 years | 18/11 | Laparoscopic colectomy | TAP 0.375% ropivacaine 75 mg | After induction of general anesthesia | 4 | - | 29 |
 |  |  | 17/11 |  | Control saline 20 ml |  | 6 | - | 28 |
McKeen, D. M | 2014 | ≥ 18 years | 0/35 | Cesarean delivery | TAP 0.25% ropivacaine 100 mg | At the end of surgery | - | 2 | 35 |
 |  |  | 0/39 |  | Control saline 40 ml |  | - | 2 | 39 |
Petersen, P. L | 2012 | 18–75 years | 9/28 | Laparoscopic cholecystectomy | TAP 0.5% ropivacaine 100 mg | Before surgical incision | - | 8 | 37 |
 |  |  | 12/25 |  | Control saline 20 ml |  | - | 13 | 37 |
Reisener, M. J | 2021 | ≥ 18 years | 54/75 | Anterior or lateral lumbar fusion | TAP 0.5% bupivacaine 100 mg | After induction of general anesthesia | 4 | - | 129 |
 |  |  | 61/60 |  | Control nothing |  | 15 | - | 121 |
Sivapurapu, V | 2021 | 18–80 years | 28/2 | Laparoscopic total extraperitoneal repair of unilateral hernia surgeries | TAP 0.25% levobupivacaine 45 mg | After induction of anesthesia | 7 | - | 30 |
 |  |  | 26/4 |  | Control nothing |  | 21 | - | 30 |
Skjelsager, A | 2013 | 18–80 years | 23/0 | Open radical prostatectomy | TAP 0.75% ropivacaine 30 mg | At the end of the surgery | - | 7 | 23 |
 |  |  | 24/0 |  | Control saline 40 ml |  | - | 8 | 24 |
Soltani Mohammadi, S | 2014 | 15–65 years | 12/10 | Kidney recipients | TAP0.25% bupivacaine 37.5 mg | After induction of anesthesia | 0 | - | 22 |
 |  |  | 14/8 |  | Control saline 15 ml |  | 2 | - | 22 |
Tan, T | 2012 | > 18 years | 0/20 | Caesarean delivery | TAP 0.25% levobupivacaine 50 mg | After the procedure, before the patients awakened | 2 | 0 | 20 |
 |  |  | 0/20 |  | Control nothing |  | 4 | 1 | 20 |
Tupper-Carey, D. A | 2017 | > 21 years | 21/8 | Urgent laparoscopic appendicectomy | TAP 0.5%bupivacaine 50 mg | After the procedure, before the patients awakened | 11 | - | 29 |
 |  |  | 25/4 |  | Control saline 10 ml |  | 7 | - | 29 |
Zhang, J | 2020 | - | 12/12 | Laparoscopic hepatectomy | TAP 0.3% ropivacaine 180Â mg | At the end of surgery | 7 | - | 24 |
 |  | - | 13/19 |  | Control saline 60 ml |  | 11 | - | 23 |
Zhang, L | 2023 | 20–60 years | 0/35 | Elective gynecological laparotomy | TAP0.375% ropivacaine 150 mg | After the induction of anesthesia | 6 | 2 | 35 |
 |  |  | 0/37 |  | Control saline 40 ml |  | 12 | 5 | 37 |